Medical University of South Carolina
Lindsay Squeglia
The goal of this study is to evaluate how citicoline, an over-the-counter supplement, versus a placebo pill (i.e., an inactive pill) affects the immune system, brain, and cognition in adolescents who may use alcohol.
Alcohol Use Disorder
Citicoline (cytidine diphosphate-choline)
Placebo oral capsule
Phase 2
| Study Type : | Interventional |
| Estimated Enrollment : | 48 participants |
| Masking : | Quadruple |
| Primary Purpose : | Treatment |
| Official Title : | Neurobehavioral and Immune Effects of Citicoline in Youth Alcohol Use Disorder |
| Actual Study Start Date : | July 2024 |
| Estimated Primary Completion Date : | February 2029 |
| Estimated Study Completion Date : | February 2029 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Citicoline 2000mg/day citicoline for 4 weeks, administered orally |
Drug: Citicoline (cytidine diphosphate-choline) |
|
Placebo Comparator: Placebo placebo capsule daily for 4 weeks, matched in appearance to citicoline to preserve double-blind, administered orally |
Drug: Placebo oral capsule |
| Ages Eligible for Study: | 16 Years to 22 Years |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Accepts Healthy Volunteers |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.